+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Albendazole in treatment of human cystic echinococcosis: 12 years of experience



Albendazole in treatment of human cystic echinococcosis: 12 years of experience



Acta Tropica 64(1/2): 79-93



The efficacy and safety of albendazole (ABZ) treatment for human echinococcosis are reviewed. Benzimidazole treatment alone requires prolonged administration over many weeks and has an unpredictable outcome. However, studies have shown that treatment with ABZ in Echinococcus granulosus infection can result in an apparent cure in up to 30% of cases with a further 40-50% showing evidence of response when followed in the short term.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 003034897

Download citation: RISBibTeXText

DOI: 10.1016/s0001-706x(96)00640-7


Related references

Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Tropica 64(1-2): 79-93, 1997

Clinical effect and safety of liposomal-albendazole and tablet-albendazole for the treatment of human cystic echinococcosis. Zhonghua Gan Zang Bing Za Zhi 19(7): 532-536, 2012

Albendazole treatment of human cystic echinococcosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 82(3): 453-459, 1988

Programme for ultrasound diagnoses and treatment with albendazole of cystic echinococcosis in asymptomatic carriers: 10 years of follow-up of cases. Acta Tropica 117(1): 1-5, 2011

Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis. Annals of Tropical Medicine and Parasitology 88(1): 49-52, 1994

Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence. Acta Tropica 83(2): 177-181, 2002

Japanese monkey (Macaca fuscata) with alveolar echinococcosis after treatment with albendazole for 10 years: serodiagnosis and determination of albendazole metabolites. Parasitology Research 106(1): 69-74, 2010

Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. Parasitology Research 115(8): 2995-3001, 2016

Albendazole Chemotherapy of disseminated echinococcosis Four years experience. Tubercle & Lung Disease 75(SUPPL 1): 93-94, 1994

Investigation on blood concentrations of albendazole sulfoxides in patients with cystic echinococcosis treated by emulsion albendazole. Endemic Diseases Bulletin 16(3): 64-66, 2001

Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial. Medicine 95(4): E2237-E2237, 2016

Efficacy of albendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases 19(3): 129-134, 2001

Could beta-myrcene be an alternative to albendazole for the treatment of experimental cystic echinococcosis?. Acta Tropica, 2018

Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology 86(1): 59-66, 1992

An observation on the ultrasonographic image in the treatment for abdominal cystic echinococcosis with emulsion albendazole. Endemic Diseases Bulletin 17(2): 75-76, 2002